These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25499971)

  • 21. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.
    Goetzl EJ; Wang W; McGiffert C; Huang MC; Gräler MH
    J Cell Biochem; 2004 Aug; 92(6):1104-14. PubMed ID: 15258896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls.
    Bolli MH; Lescop C; Nayler O
    Curr Top Med Chem; 2011; 11(6):726-57. PubMed ID: 21261590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells.
    Costello RW; Maloney M; Atiyeh M; Gleich G; Walsh MT
    Int J Mol Sci; 2011; 12(5):3237-49. PubMed ID: 21686182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.
    Kipp M; Amor S
    Mult Scler; 2012 Mar; 18(3):258-63. PubMed ID: 22383435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of the lysophospholipid receptor genes during mouse early development.
    Ohuchi H; Hamada A; Matsuda H; Takagi A; Tanaka M; Aoki J; Arai H; Noji S
    Dev Dyn; 2008 Nov; 237(11):3280-94. PubMed ID: 18924241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain.
    Langeslag M; Kress M
    Expert Opin Ther Targets; 2020 Sep; 24(9):869-884. PubMed ID: 32589067
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice.
    Yang AH; Ishii I; Chun J
    Biochim Biophys Acta; 2002 May; 1582(1-3):197-203. PubMed ID: 12069829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophospholipid activation of G protein-coupled receptors.
    Mutoh T; Chun J
    Subcell Biochem; 2008; 49():269-97. PubMed ID: 18751915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
    Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
    Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.
    Mao-Draayer Y; Sarazin J; Fox D; Schiopu E
    Clin Immunol; 2017 Feb; 175():10-15. PubMed ID: 27890706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis.
    Pyne NJ; Dubois G; Pyne S
    Biochim Biophys Acta; 2013 Jan; 1831(1):228-38. PubMed ID: 22801038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52.
    Radeke HH; von Wenckstern H; Stoidtner K; Sauer B; Hammer S; Kleuser B
    J Immunol; 2005 Mar; 174(5):2778-86. PubMed ID: 15728487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
    Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
    Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targets of FTY720 (fingolimod).
    Pitman MR; Woodcock JM; Lopez AF; Pitson SM
    Curr Mol Med; 2012 Dec; 12(10):1207-19. PubMed ID: 22834825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of LPA and S1P on the nervous system and implications for their involvement in disease.
    Herr DR; Chun J
    Curr Drug Targets; 2007 Jan; 8(1):155-67. PubMed ID: 17266539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.